| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 177.85B | 181.30B | 210.22B | 233.88B | 273.68B |
| Gross Profit | 33.25B | 32.71B | 37.45B | 39.84B | 65.73B |
| EBITDA | 22.30B | 30.80B | 26.54B | 28.36B | 56.67B |
| Net Income | -3.35B | 2.90B | 4.41B | 8.82B | 17.09B |
Balance Sheet | |||||
| Total Assets | 489.54B | 494.01B | 488.90B | 482.47B | 462.54B |
| Cash, Cash Equivalents and Short-Term Investments | 30.34B | 32.96B | 37.37B | 35.06B | 35.52B |
| Total Debt | 195.38B | 194.48B | 187.03B | 176.29B | 169.81B |
| Total Liabilities | 303.13B | 299.48B | 295.38B | 290.13B | 283.92B |
| Stockholders Equity | 110.67B | 119.44B | 123.16B | 123.15B | 118.68B |
Cash Flow | |||||
| Free Cash Flow | 8.16B | 1.40B | 6.98B | -4.72B | 13.16B |
| Operating Cash Flow | 22.52B | 23.20B | 29.02B | 26.35B | 50.09B |
| Investing Cash Flow | -9.37B | -20.28B | -27.34B | -25.68B | -35.61B |
| Financing Cash Flow | -12.82B | -6.57B | -1.08B | -2.18B | -16.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | HK$130.97B | 12.69 | 4.26% | 4.59% | -28.50% | 23.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | HK$12.51B | 17.75 | 6.91% | 1.29% | 20.56% | 254.64% | |
60 Neutral | HK$47.67B | 10.05 | 9.16% | 4.82% | 0.40% | 62.35% | |
53 Neutral | HK$36.83B | ― | 7.49% | 3.30% | -5.50% | 1248.29% | |
49 Neutral | HK$2.00B | -2.49 | -5.53% | ― | -14.85% | ― | |
48 Neutral | HK$739.99M | 2.64 | 2.06% | ― | 0.18% | ― |